Regulation of Glut 1 Function

Glut 1 功能的调节

基本信息

  • 批准号:
    6771818
  • 负责人:
  • 金额:
    $ 24.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-07-15 至 2007-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Glut1 glucose transporter is an integral plasma membrane protein that is expressed in many cells and tissues. We have found that the acute (1-2 h) stimulation of Glut 1-mediated glucose transport is controlled by "activation "' of Glut1 transporters pre-existing in the plasma membrane. We have also found that a fraction of cell Glut 1 is bound by stomatin resulting in inhibition of Glut1 function. More recently we have made the novel observation that a significant fraction of Glut1, and virtually all of stomatin, reside in the cholesterol- and sphingolipid-rich detergent-resistant membranes (DRMs), and that a fraction of Glut l (but not stomatin) moves out of the DRMs upon stimulation of glucose transport in response to inhibition of oxidative phosphorylation. Based on our results we propose that Glut 1 localized in the plasma membrane exists in two-states, namely inactive and active. This proposal will be tested by the following Specific Aims: 1) Test the hypothesis that association of stomatin and Glutl leads to inhibition of Glut1 function, 2) Test the hypothesis that Glutl dissociates from stomatin during its activation in response to inhibition of oxidative phosphorylation and following stimulation of AMP-activated protein kinase (AMPK), 3) Test the hypothesis that Glut l present in plasma membrane DRMs are palmitoylated and the movement of Glutl out of this micro-domain reflects its de-palmitoylation, and 4) Identify Glutl-binding proteins under basal and stimulated conditions. An understanding of the molecular events leading to control of Glut l function should provide new insights into potentially novel physiological and pharmacological regulators of this important transporter.
描述(由申请人提供):Glut 1葡萄糖转运蛋白是一种在许多细胞和组织中表达的整合质膜蛋白。我们发现Glut 1介导的葡萄糖转运的急性(1-2小时)刺激是由预先存在于质膜中的Glut 1转运蛋白的“激活”控制的。我们还发现,细胞Glut 1的一部分是由气孔蛋白导致Glut 1功能的抑制绑定。最近,我们已经进行了新的观察,即显著部分的Glut 1和几乎所有的气孔蛋白存在于富含胆固醇和鞘脂的耐洗涤剂膜(DRM)中,并且在响应于氧化磷酸化的抑制而刺激葡萄糖转运时,一部分Glut 1(但不是气孔蛋白)移出DRM。基于我们的研究结果,我们建议,Glut 1定位在质膜上存在两种状态,即无活性和活性。这一建议将通过以下具体目标进行检验:2)检验Glutl在响应氧化磷酸化抑制的活化过程中和在AMP活化蛋白激酶(AMPK)刺激后从气孔蛋白解离的假设,3)检验存在于质膜DRM中的Glutl被棕榈酰化并且Glutl移出该微结构域反映其去棕榈酰化的假设,以及4)鉴定基础和刺激条件下的Glutl结合蛋白。 对导致控制Glutl功能的分子事件的理解应该为这种重要转运蛋白的潜在的新型生理和药理调节剂提供新的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

FARAMARZ ISMAIL-BEIGI其他文献

FARAMARZ ISMAIL-BEIGI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('FARAMARZ ISMAIL-BEIGI', 18)}}的其他基金

Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
胰岛素和胰高血糖素中互补葡萄糖响应构象开关的分子工程
  • 批准号:
    10263301
  • 财政年份:
    2020
  • 资助金额:
    $ 24.86万
  • 项目类别:
Molecular endocrinology and principles of diabetes therapeutics: application to ultra-stable insulin analogs
分子内分泌学和糖尿病治疗原理:超稳定胰岛素类似物的应用
  • 批准号:
    10155480
  • 财政年份:
    2020
  • 资助金额:
    $ 24.86万
  • 项目类别:
Molecular engineering of complementary glucose-responsive conformational switches in insulin and glucagon
胰岛素和胰高血糖素中互补葡萄糖响应构象开关的分子工程
  • 批准号:
    10443890
  • 财政年份:
    2020
  • 资助金额:
    $ 24.86万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    7730065
  • 财政年份:
    2009
  • 资助金额:
    $ 24.86万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    8110071
  • 财政年份:
    2009
  • 资助金额:
    $ 24.86万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    7884582
  • 财政年份:
    2009
  • 资助金额:
    $ 24.86万
  • 项目类别:
Novel PET Imaging of Glucose Transport
葡萄糖转运的新型 PET 成像
  • 批准号:
    8322155
  • 财政年份:
    2009
  • 资助金额:
    $ 24.86万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    6685004
  • 财政年份:
    2003
  • 资助金额:
    $ 24.86万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    7070598
  • 财政年份:
    2003
  • 资助金额:
    $ 24.86万
  • 项目类别:
Regulation of Glut 1 Function
Glut 1 功能的调节
  • 批准号:
    6882034
  • 财政年份:
    2003
  • 资助金额:
    $ 24.86万
  • 项目类别:

相似海外基金

Discovery of cell membrane permeable HDAC6 PROTACs
细胞膜渗透性 HDAC6 PROTAC 的发现
  • 批准号:
    23K06061
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Control of cell membrane permeability by intense electrical pulses and development of innovative food processing
通过强电脉冲控制细胞膜渗透性和创新食品加工的发展
  • 批准号:
    23H01403
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of a method to inhibit epithelial-mesenchymal transition by targeting cell membrane phospholipids
开发一种通过靶向细胞膜磷脂抑制上皮间质转化的方法
  • 批准号:
    23K06103
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Host cell membrane perforation during invasion by Toxoplasma gondii
弓形虫入侵过程中宿主细胞膜穿孔
  • 批准号:
    10587658
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Cell membrane-targeting proteoglycan chimeras as selective growth factor signaling actuators
作为选择性生长因子信号传导执行器的细胞膜靶向蛋白聚糖嵌合体
  • 批准号:
    10588085
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
High throughput antibody discovery against cell membrane bound target proteins using innovative MOD technology for direct screening in single-cell assays
使用创新的 MOD 技术发现针对细胞膜结合靶蛋白的高通量抗体,用于单细胞测定中的直接筛选
  • 批准号:
    10698891
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Three-dimensional measurement of cell-sercreted molecules using probe-type artificial cell membrane systems
使用探针型人工细胞膜系统对细胞分泌分子进行三维测量
  • 批准号:
    23H01822
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Probing the specific interactions of AlphaA- crystallin and its aging- and cataract-associated forms with lens cell membrane mimics
探讨 AlphaA-晶状体蛋白及其与衰老和白内障相关的形式与晶状体细胞膜模拟物的特定相互作用
  • 批准号:
    10667060
  • 财政年份:
    2023
  • 资助金额:
    $ 24.86万
  • 项目类别:
Nanostructure transfer to cell membrane by cytoplasmic gelation and its optical sensor application
细胞质凝胶化纳米结构转移至细胞膜及其光学传感器应用
  • 批准号:
    22K18760
  • 财政年份:
    2022
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
An extedned research of cell membrane domains based on the probes of membrane molecules
基于膜分子探针的细胞膜域扩展研究
  • 批准号:
    22H00359
  • 财政年份:
    2022
  • 资助金额:
    $ 24.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了